Skip to content

4D pharma plc

CIK 0001830162

← back to feed
Revenue (TTM)
$718K
+4.1% YoY FY Dec 2021
Net Income (TTM)
−$31.94M
−4.7% YoY FY Dec 2021
EPS Diluted (TTM)
—
FY Dec 2021
Gross Margin
—
FY Dec 2021
Operating Margin
-5,189.6%
FY Dec 2021
Net Margin
-4,448.2%
FY Dec 2021
Free Cash Flow (TTM)
−$38.2M
FY Dec 2021
Cash
$20.97M
FY Dec 2021
Total Debt
$11.84M
FY Dec 2021
Shares Outstanding
180.3M sh
FY Dec 2021

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings